Childhood vaccine purchase costs in the public sector: Past trends, future expectations

American Journal of Public Health

Volumn 92, Issue 12, 2002, Pages 1982-1987

  Davis, Matthew M ^a,b,e   Zimmerman, Jessica L ^a,c   Wheeler, John R C ^a,d   Freed, Gary L ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Department of Obstetrics and Gynecology   (United States)

^c CHEAR Unit   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ARTICLE; CALCULATION; CONFIDENCE INTERVAL; COST BENEFIT ANALYSIS; DRUG COST; DRUG MARKETING; FINANCIAL MANAGEMENT; HUMAN; LINEAR REGRESSION ANALYSIS; PUBLIC HEALTH; PUBLIC HEALTH SERVICE;

EID: 0036891762     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.92.12.1982     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. Impact of vaccines universally recommended for children - United States, 1900-1998. MMWR Morb Mortal Wkly Rep. 1999;48:243-247.
2. Shepard DS, Walsh JA, Kleinau E, Stansfield S, Bhalotra S. Setting priorities for the Children's Vaccine Initiative: A cost-effectiveness approach. Vaccine. 1995; 13:707-714.
3. Coffield AB, Maciosek MV, McGinnis JM, et al. Priorities among recommended clinical preventive services. Am J Prev Med. 2001;21:1-9.
4. Institute of Medicine. Calling the Shots: Immunization Finance Policies and Practices. Washington, DC: The National Academy Press; 2000.
5. Strategies to sustain success in childhood immunizations. The National Vaccine Advisory Committee. JAMA. 1999;282:363-370.
6. Centers for Disease Control and Prevention. Recommended childhood immunization schedule - United States, 2001. MMWR Morb Mortal Wkly Rep. 2001; 50:7-9, 19.
7. Committee on Infectious Diseases, American Academy of Pediatrics. 1988 Red Book: Report of the Committee on Infectious Diseases. Elk Grove Village, Ill: American Academy of Pediatrics; 1988.
8. Hinman AR. Immunizations in the United States. Pediatrics. 1990;86:1064-1066.
9. Committee on Infectious Diseases, American Academy of Pediatrics. 1991 Red Book: Report of the Committee on Infectious Diseases. Elk Grove Village, Ill: American Academy of Pediatrics; 1991.
10. Committee on Infectious Diseases, American Academy of Pediatrics. 1994 Red Book: Report of the Committee on Infectious Diseases. Elk Grove Village, Ill: American Academy of Pediatrics; 1994.
11. Centers for Disease Control. Update on adult immunization recommendations of the immunization practices advisory committee (ACIP). MMWR Morb Mortal Wkly Rep. 1991;40:1-52.
12. Centers for Disease Control and Prevention. General recommendations on immunization recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1994;43:1-38.
13. Centers for Disease Control and Prevention. Recommended childhood immunization schedule - United States, January-June 1996. MMWR Morb Mortal Wkly Rep. 1996;44:940-943.
14. Centers for Disease Control and Prevention. Recommended childhood immunization schedule - United States, July-December 1996. MMWR Morb Mortal Wkly Rep. 1996;45:635-638.
15. Centers for Disease Control and Prevention. Recommended childhood immunization schedule - United States, 1997. MMWR Morb Mortal Wkly Rep. 1997; 46:35-39.
16. Centers for Disease Control and Prevention. Recommended childhood immunization schedule - United States, 1998. MMWR Morb Mortal Wkly Rep. 1998; 47:8-12.
17. Centers for Disease Control and Prevention. Recommended childhood immunization schedule - United States, 1999. MMWR Morb Mortal Wkly Rep. 1999; 48:8-16.
18. Centers for Disease Control and Prevention. Recommended childhood immunization schedule - United States, 2000. MMWR Morb Mortal Wkly Rep. 2000; 49:35-38, 47.
19. Centers for Disease Control and Prevention. Vaccines for Children (VFC) Program Vaccine Price List. Available at: http://www.cdc.gov/nip/vfc/cdc_vac_ price_list.htm. Accessed September 2, 2002.
20. Institute of Medicine. Vaccines for the 21st Century: A Tool for Decisionmaking. Washington, DC: National Academy Press; 1999.
21. Orenstein WA, Hinman AR, Rodewald LE. Public health considerations - United States. In: SA Plotkin, WA Orenstein, eds. Vaccines. 3rd Ed. Philadelphia, Pa: WB Saunders; 1999:1006-1032.
22. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization. MMWR Morb Mortal Wkly Rep. 1999; 48(RR-12):1-15.
23. Bureau of Labor Statistics, US Department of Labor. Consumer Price Index. Available at: ftp://ftp.bls. gov/pub/special.requests/cpi/cpiai.txt. Accessed September 3, 2002.
24. National Institute of Allergy and Infectious Diseases. The Jordan Report 2000: Accelerated Development of Vaccines. Bethesda, MD: National Institutes of Health; 2000.
25. FDA panel rejects GlaxoSmithKline vaccine for children. Wall Street Journal. March 8, 2001;B2.
26. Weniger BG, Chen RT, Jacobson SH, et al. Addressing the challenges to immunization practice with an economic algorithm for vaccine selection. Vaccine. 1998;16:1885-1897.
27. Davis MM, Clark SJ, Freed GL. States' concerns and strategies regarding purchase of Prevnar. Pediatr Res. 2001;49:151A.
28. Davis MM, Andreae M, Freed GL. Physicians' early challenges related to the pneumococcal conjugate vaccine. Ambul Pediatr. 2001;1:302-305.
29. Lieu TA, Cochi SL, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA. 1994;271:375-381.
30. Black S, Lieu TA, Ray GT, Capra A, Shinefield HR. Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente. Vaccine. 2000;19(suppl):S83-S86.